Liraglutide: all 338 studies that test it

Page 3 of 4. Open to participants first (20), then studies with results posted, then the rest; newest registration first within each.

• A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 YearsCompletedNCT02696148Phase 1
• Effect of GLP-1 on AngiogenesisCompletedNCT02686177Phase 4
• Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 DiabetesTerminatedNCT02674893Phase 4
• Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian DescentCompletedNCT02660047Phase 4
• Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes PatientsCompletedNCT02655770Phase 4
• Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and BloodCompletedNCT02650206Phase 1
• Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 DiabetesCompletedNCT02617654Phase 2
• Preoperative Condition in Giant Obese PatientsCompletedNCT02616003Phase 4
• Incretin-based Therapy in Preclinical Type 1 Diabetes in AdultsStatus unknownNCT02611232Phase 2
• Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary StenosisCompletedNCT02602600Phase 4
• The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying RateStatus unknownNCT02584582Phase 2/3
• Antiproteinuric Effects of Liraglutide TreatmentCompletedNCT02545738Phase 4
• Treatment of Hypoglycemia Following Gastric Bypass SurgeryCompletedNCT02527993Phase 4
• Effects of Glucagon Like Peptide-1 on No-reflowStatus unknownNCT02507128Not applicable
• The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)Status unknownNCT02501850Phase 4
• Effects of Glucagon Like Peptide-1 on Haemodynamic ParametersStatus unknownNCT02490176Not applicable
• Improving Beta Cell Function in Mexican American Women With PrediabetesCompletedNCT02488057Phase 4
• Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary SyndromeCompletedNCT02483299Phase 4
• The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell FunctionCompletedNCT02473809Phase 4
• Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy StudyWithdrawnNCT02472717Phase 2
• Cognitive Dysfunction and Glucagon-like Peptide-1 AgonistsCompletedNCT02423824Phase 3
• Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes SubjectsCompletedNCT02408705Phase 2
• The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in HumansCompletedNCT02403284Phase 4
• The Lira Pump TrialCompletedNCT02351232Phase 2/3
• Effects of Liraglutide on ER Stress in Obese Patients With Type 2 DiabetesStatus unknownNCT02344186Phase 4
• Liraglutide to Improve corONary Haemodynamics During Exercise streSSCompletedNCT02315001Phase 2
• Trial for People With Established Type 2 Diabetes During RamadanCompletedNCT02292290Phase 4
• The Effect of Liraglutide in Patients With Prediabetes and Kidney FailureWithdrawnNCT02284230Phase 2
• Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male SubjectsCompletedNCT02235961Phase 1
• Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid SecretionTerminatedNCT02231658Phase 1
• Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectorsCompletedNCT02207348Phase 1
• Liraglutide Actions on the Liver: Effects on Glucose PhosphorylationWithdrawnNCT02198209Phase 4
• PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary SyndromeCompletedNCT02187250Phase 4
• Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With PrediabetesCompletedNCT02140983Phase 1
• Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin InjectionsCompletedNCT02113332Phase 2
• Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes.WithdrawnNCT02109315Phase 1
• Liraglutide as add-on to Insulin in Type 1 DiabetesCompletedNCT02092896Phase 3
• Effect of Repeated Administration of Liraglutide on Insulinogenic IndicesCompletedNCT02089256Phase 4
• GLP-1 Response and Effect in Individuals With Obesity Causing Genetic MutationsCompletedNCT02082496Phase 2
• A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes MellitusStatus unknownNCT02059564Phase 1
• Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)Status unknownNCT02055014Phase 4
• Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)CompletedNCT02043054Phase 3
• Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical TreatmentCompletedNCT02041234Phase 4
• Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes MellitusCompletedNCT02036372Not applicable
• Liraglutide Efficacy on Glucocorticoid Induced Hyperglycemia in Patients High Risk for DiabetesStatus unknownNCT02016846Phase 3
• Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion InjuryStatus unknownNCT02001363Not applicable
• Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.CompletedNCT01931982Phase 4
• A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy SubjectsCompletedNCT01916174Phase 1
• Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on MetforminCompletedNCT01911468Phase 4
• Polycystic Ovary Syndrome and LiraglutideCompletedNCT01899430Phase 4
• Liraglutide in Newly Onset Type 1 Diabetes.CompletedNCT01879917Phase 2/3
• Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?Status unknownNCT01845259Phase 2
• Evaluating Liraglutide in Alzheimer's DiseaseStatus unknownNCT01843075Phase 2
• The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced DiabetesCompletedNCT01795248Phase 4
• Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell FunctionStatus unknownNCT01790308Phase 4
• A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 YearsCompletedNCT01789086Phase 1
• Differences in Endothelial Function Amongst Sitagliptin and Liraglutide UsersCompletedNCT01785043Phase 4
• Incretin Effect on the Immunological PhenotypeCompletedNCT01782261Phase 2
• Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 PatientsCompletedNCT01761318Phase 4
• Blood Pressure Outcomes With Liraglutide TherapyCompletedNCT01755572Phase 4
• SAFEGUARD: Pleiotropic Effects of Incretin Based TherapiesCompletedNCT01744236Phase 4
• GLP-1 and Microvascular Function in Type 2 DiabetesCompletedNCT01740921Not applicable
• Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and ObeseCompletedNCT01739049Phase 4
• Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 DiabetesWithdrawnNCT01722227Phase 3
• The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy VolunteersCompletedNCT01695109Phase 4
• Effects of Liraglutide on Kidney Function in Type 2 Diabetic PatientsCompletedNCT01664676Phase 4
• Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DMCompletedNCT01658501Phase 2
• Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II DiabeticsCompletedNCT01654120Phase 4
• Study of Liraglutide in Individuals With Type 2 Diabetes Using InsulinTerminatedNCT01628445Phase 3
• Safety and Tolerability of Liraglutide in Healthy Japanese VolunteersCompletedNCT01620476Phase 1
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese VolunteersCompletedNCT01620463Phase 1
• Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 DiabetesCompletedNCT01615978Phase 1
• Liraglutide in Type 1 DiabetesCompletedNCT01612468Phase 4
• The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)CompletedNCT01610934Phase 2/3
• Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic PatientsCompletedNCT01599338Not applicable
• Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric BandingTerminatedNCT01597531Phase 4
• The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 DiabetesCompletedNCT01595789Phase 4
• A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 DiabetesWithdrawnNCT01593137Phase 4
• GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic PatientsStatus unknownNCT01592279Phase 4
• DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R AgonistsCompletedNCT01575301Not applicable
• Liraglutide Effects on Memory in Healthy SubjectsCompletedNCT01550653Phase 1
• Liraglutide Use in Prader-Willi SyndromeTerminatedNCT01542242Phase 4
• The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 DiabetesCompletedNCT01536665Phase 1
• Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pHCompletedNCT01518166Phase 1
• Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both MedicationsCompletedNCT01518101Phase 4
• Metabolism and Excretion of Liraglutide in Healthy Male VolunteersCompletedNCT01517568Phase 1
• Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 DiabetesCompletedNCT01517555Phase 1
• Study of RO6807952 in Patients With Diabetes Mellitus Type 2TerminatedNCT01516476Phase 2
• Effect of Liraglutide on Heart Frequency in Healthy VolunteersCompletedNCT01516255Phase 1
• Safety and Tolerability of Liraglutide in Healthy Japanese Male VolunteersCompletedNCT01515592Phase 1
• Comparison of Two Liraglutide Formulations in Healthy SubjectsCompletedNCT01515579Phase 1
• Bioequivalence of Two Liraglutide Formulations in Healthy VolunteersCompletedNCT01515553Phase 1
• Comparison of Three Liraglutide Formulations in Healthy VolunteersCompletedNCT01514487Phase 1
• Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy VolunteersCompletedNCT01513525Phase 1
• Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 DiabetesCompletedNCT01511692Phase 1
• Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic AgentCompletedNCT01511198Phase 2
• Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control GroupCompletedNCT01511185Phase 1
• Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 DiabetesCompletedNCT01511172Phase 2
• Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male VolunteersCompletedNCT01511159Phase 1
• Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 DiabetesCompletedNCT01509755Phase 2

← Liraglutide overview